Search results

Search for "hybrid drugs" in Full Text gives 3 result(s) in Beilstein Journal of Organic Chemistry.

Facile synthesis of hydantoin/1,2,4-oxadiazoline spiro-compounds via 1,3-dipolar cycloaddition of nitrile oxides to 5-iminohydantoins

  • Juliana V. Petrova,
  • Varvara T. Tkachenko,
  • Victor A. Tafeenko,
  • Anna S. Pestretsova,
  • Vadim S. Pokrovsky,
  • Maxim E. Kukushkin and
  • Elena K. Beloglazkina

Beilstein J. Org. Chem. 2025, 21, 1552–1560, doi:10.3762/bjoc.21.118

Graphical Abstract
  • developed for existing spiro systems to the new hybrid drugs. In this work a similar modification of imidazolidine derivatives was performed for the first time for the synthesis of spiro-hydantoins. The title reactions were carried out using two alternative techniques for the generation of the reactive 1,3
PDF
Album
Supp Info
Full Research Paper
Published 31 Jul 2025

Matsuda–Heck reaction with arenediazonium tosylates in water

  • Ksenia V. Kutonova,
  • Marina E. Trusova,
  • Andrey V. Stankevich,
  • Pavel S. Postnikov and
  • Victor D. Filimonov

Beilstein J. Org. Chem. 2015, 11, 358–362, doi:10.3762/bjoc.11.41

Graphical Abstract
  • obtainment of valuable 3-chloropropyl cinnamates (Table 2, entries 11–13) with good to excellent yields. Haloalkyl cinnamates are important building blocks in the synthesis of nitric oxide-donor hybrid drugs for the treatment of cardiovascular disease and cancer [14][15][16][17]. Previously, haloalkyl
PDF
Album
Supp Info
Full Research Paper
Published 16 Mar 2015

Chemical–biological characterization of a cruzain inhibitor reveals a second target and a mammalian off-target

  • Jonathan W. Choy,
  • Clifford Bryant,
  • Claudia M. Calvet,
  • Patricia S. Doyle,
  • Shamila S. Gunatilleke,
  • Siegfried S. F. Leung,
  • Kenny K. H. Ang,
  • Steven Chen,
  • Jiri Gut,
  • Juan A. Oses-Prieto,
  • Jonathan B. Johnston,
  • Michelle R. Arkin,
  • Alma L. Burlingame,
  • Jack Taunton,
  • Matthew P. Jacobson,
  • James M. McKerrow,
  • Larissa M. Podust and
  • Adam R. Renslo

Beilstein J. Org. Chem. 2013, 9, 15–25, doi:10.3762/bjoc.9.3

Graphical Abstract
  • of this new class of inhibitors. Keywords: activity-based probes; Chagas’ disease; cruzain; CYP51; 14-α-demethylase; hybrid drugs; Trypanosoma cruzi; Introduction The kinetoplastid protozoan Trypanosoma cruzi is the causative agent of Chagas’ disease, a leading cause of heart failure in endemic
PDF
Album
Supp Info
Full Research Paper
Published 04 Jan 2013
Other Beilstein-Institut Open Science Activities